122 results
Page 3 of 7
425
EX-10.2
vegy5h irrfl3ncm
29 Mar 21
Business combination disclosure
7:27am
425
EX-10.1
t9vp4nr
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-10.1
jcwh cxj7igmzfp5kz1p
28 Jan 21
Cost Associated with Exit or Disposal Activities
8:01am
8-K
EX-1.1
ygdrxf
4 Mar 20
Entry into a Material Definitive Agreement
8:37am
8-K
EX-1.1
xl3lps95qey7qkpsssbe
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-10.1
9cegq5s vjv68
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm